Overpatented, Overpriced:

How Excessive Pharmaceutical Patenting is Extending Monopolies and Driving up Drug Prices

Download the Report

This report analyzes the twelve best selling drugs in the United States and reveals that drugmakers file hundreds of patent applications – the vast majority of which are granted – to extend their monopolies far beyond the twenty years of protection intended under U.S. patent law.

These patents are used by drugmakers for the purpose of forestalling generic competition while continuing to increase the price of these drugs. Here are our main findings.


Download the Report read the other overpatented reports

Partner with us now to build
a more just and equitable
medicine system for all.